Abstract:Complex changes in the brain microenvironment following traumatic brain injury (TBI) can cause neurological impairments for which there are few efficacious therapeutic interventions. The reactivity of astrocytes is one of the keys to microenvironmental changes, such as neuroinflammation, but its role and the molecular mechanisms that underpin it remain unclear. Male C57BL/6J mice were subjected to the controlled cortical impact (CCI) to develop a TBI model. The specific ligand of AXL receptor tyrosine kinase (AXL), recombinant mouse growth arrest-specific 6 (rmGas6) was intracerebroventricularly administered, and selective AXL antagonist R428 was intraperitoneally applied at 30 min post-modeling separately. Post-TBI assessments included neurobehavioral assessments, transmission electron microscopy, immunohistochemistry, and western blotting. Real-time polymerase chain reaction (RT-PCR), siRNA transfection, and flow cytometry were performed for mechanism assessments in primary cultured astrocytes. AXL is upregulated mainly in astrocytes after TBI and promotes astrocytes switching to a phenotype that exhibits the capability of ingesting degenerated neurons or debris. As a result, this astrocytic transformation promotes the limitation of neuroinflammation and recovery of neurological dysfunction. Pharmacological inhibition of AXL in astrocytes significantly decreased astrocytic phagocytosis both in vivo and in primary astrocyte cultures, in contrast to the effect of treatment with the rmGas6. AXL activates the signal transducer and activator of the transcription 1 (STAT1) pathway thereby further upregulating ATP-binding cassette transporter 1 (ABCA1). Moreover, the supernatant from GAS6-depleted BV2 cells induced limited enhancement of astrocytic phagocytosis in vitro. Our work establishes the role of AXL in the transformation of astrocytes to a phagocytic phenotype via the AXL/STAT1/ABCA1 pathway which contributes to the separation of healthy brain tissue from injury-induced cell debris, further ameliorating neuroinflammation and neurological impairments after TBI. Collectively, our findings provide a potential therapeutic target for TBI.

Astrocyte-derived exosome-transported GJA1-20k attenuates traumatic brain injury in rats

Astrocytes‐derived exosomes induce neuronal recovery after traumatic brain injury via delivering gap junction alpha 1‐20 k

CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions

Astrocyte-derived exosomes protect hippocampal neurons after traumatic brain injury by suppressing mitochondrial oxidative stress and apoptosis

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Astrocyte–neuron crosstalk through extracellular vesicle-shuttled miRNA-382-5p promotes traumatic brain injury

Astrocyte-Derived Exosomal miR-148a-3p Suppresses Neuroinflammation and Restores Neurological Function in Traumatic Brain Injury by Regulating the Microglial Phenotype

A Novel Cognitive Impairment Mechanism That Astrocytic P-Connexin 43 Promotes Neuronic Autophagy Via Activation of P2X7R and Down-Regulation of GLT-1 Expression in the Hippocampus Following Traumatic Brain Injury in Rats.

TGFβ1 Alleviates Axonal Injury by Regulating Microglia/macrophages Alternative Activation in Traumatic Brain Injury

Astrocyte-Specific Deletion of Sox2 Promotes Functional Recovery after Traumatic Brain Injury

Molecular Mechanisms and Signaling Pathways of Reactive Astrocytes Responding to Traumatic Brain Injury

Neuronic Autophagy Contributes to P-Connexin 43 Degradation in Hippocampal Astrocytes Following Traumatic Brain Injury in Rats

Dual Roles of Astrocytes in Plasticity and Reconstruction after Traumatic Brain Injury

The Kinase Inhibitory Region of SOCS3 Attenuates Reactive Astrogliosis and Astroglial Scar in Mice after Traumatic Brain Injury.

A Pvr–AP-1–Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury

Long noncoding RNA NKILA transferred by astrocyte-derived extracellular vesicles protects against neuronal injury by upregulating NLRX1 through binding to mir-195 in traumatic brain injury

Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury

Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model

Progress of Astrocyte Activation and Traumatic Brain Injury Research

Elevated Hippocampal CD24 in Astrocytes Participates in Neural Regeneration Possibly Via Activating SHP2/ERK Pathway after Experimental Traumatic Brain Injury in Mice.

FTY720 Reduces Endothelial Cell Apoptosis and Remodels Neurovascular Unit after Experimental Traumatic Brain Injury